JP2011188853A5

JP2011188853A5 -

Download PDF

Info

Publication number: JP2011188853A5
Authority: JP; Japan
Prior art keywords: seq; sequence represented; nucleic acid; base sequence; cancer
Prior art date: 2011-02-17
Legal status : Granted

Application number

JP2011032501A

Other languages

English (en)

Japanese (ja)

Other versions

JP2011188853A (ja

JP5901046B2 (ja

Filing date

2011-02-17

Publication date

2014-04-03

2011-02-17 Application filed filed Critical

2011-02-17 Priority to JP2011032501A priority Critical patent/JP5901046B2/ja

2011-02-17 Priority claimed from JP2011032501A external-priority patent/JP5901046B2/ja

2011-02-18 Priority to US13/030,485 priority patent/US9404158B2/en

2011-09-29 Publication of JP2011188853A publication Critical patent/JP2011188853A/ja

2013-02-05 Priority to US13/759,101 priority patent/US9115405B2/en

2014-04-03 Publication of JP2011188853A5 publication Critical patent/JP2011188853A5/ja

2016-04-06 Application granted granted Critical

2016-04-06 Publication of JP5901046B2 publication Critical patent/JP5901046B2/ja

2016-08-02 Priority to US15/226,278 priority patent/US10011881B2/en

Status Expired - Fee Related legal-status Critical Current

2031-02-17 Anticipated expiration legal-status Critical

Links

108020004707 nucleic acids Proteins 0.000 claims 12
102000039446 nucleic acids Human genes 0.000 claims 12
150000007523 nucleic acids Chemical class 0.000 claims 12
108020004999 messenger RNA Proteins 0.000 claims 9
206010028980 Neoplasm Diseases 0.000 claims 8
201000011510 cancer Diseases 0.000 claims 8
238000000034 method Methods 0.000 claims 7
229920001184 polypeptide Polymers 0.000 claims 7
102000004196 processed proteins & peptides Human genes 0.000 claims 7
108090000765 processed proteins & peptides Proteins 0.000 claims 7
238000000691 measurement method Methods 0.000 claims 5
125000003275 alpha amino acid group Chemical group 0.000 claims 4
210000004027 cell Anatomy 0.000 claims 4
238000001514 detection method Methods 0.000 claims 3
238000003199 nucleic acid amplification method Methods 0.000 claims 3
FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 2
108091006172 SLC21 Proteins 0.000 claims 2
239000013604 expression vector Substances 0.000 claims 2
239000012634 fragment Substances 0.000 claims 2
238000005259 measurement Methods 0.000 claims 2
239000000126 substance Substances 0.000 claims 2
206010009944 Colon cancer Diseases 0.000 claims 1
206010061902 Pancreatic neoplasm Diseases 0.000 claims 1
150000001413 amino acids Chemical class 0.000 claims 1
230000003321 amplification Effects 0.000 claims 1
229940022399 cancer vaccine Drugs 0.000 claims 1
238000009566 cancer vaccine Methods 0.000 claims 1
208000029742 colonic neoplasm Diseases 0.000 claims 1
239000002299 complementary DNA Substances 0.000 claims 1
210000004748 cultured cell Anatomy 0.000 claims 1
238000012258 culturing Methods 0.000 claims 1
210000001151 cytotoxic T lymphocyte Anatomy 0.000 claims 1
239000003814 drug Substances 0.000 claims 1
230000001939 inductive effect Effects 0.000 claims 1
208000015486 malignant pancreatic neoplasm Diseases 0.000 claims 1
201000002528 pancreatic cancer Diseases 0.000 claims 1
208000008443 pancreatic carcinoma Diseases 0.000 claims 1
230000000069 prophylactic effect Effects 0.000 claims 1
238000003757 reverse transcription PCR Methods 0.000 claims 1
238000012216 screening Methods 0.000 claims 1
229940124597 therapeutic agent Drugs 0.000 claims 1

JP2011032501A 2010-02-19 2011-02-17 ＯＡＴＰ１Ｂ３ｍＲＮＡの新規な選択的スプライシングバリアント Expired - Fee Related JP5901046B2 (ja)